Credit: CC0 Public Domain The emerging field of diabetology—a sub-specialty of endocrinology focused on the treatment of people with diabetes—is intended to address an emerging crisis in health care: Nearly one-third of Americans has a type 2 diabetes diagnosis or has prediabetes. Compounding this problem, numbers of endocrinologists, the physicians who specialize in treating diabetes, […]Continue Reading ...
MONDAY, Sept. 10, 2018 — Higher levels of aldosterone are associated with insulin resistance and incident type 2 diabetes mellitus among multiethnic individuals, according to a study published in the Sept. 4 issue of the Journal of the American Heart Association. Joshua J. Joseph, M.D., from The Ohio State University in Columbus, and colleagues assessed […]Continue Reading ...
Credit: National Institute of Diabetes and Digestive and Kidney Diseases Diabetes affects a body from head to toe. Now there’s a resource that illustrates its effect on both—and all the parts in between. Thanks to research, what we know about diabetes and how to treat it has grown vastly over time. Now, researchers at the […]Continue Reading ...
It doesn’t matter if it’s rye, oats, or wheat. As long as it is wholegrain, it can prevent type 2 diabetes. This is the finding of a new study from researchers at Chalmers University of Technology, Sweden, and the Danish Cancer Society Research Center. The comprehensive study is a strong confirmation of previous research findings […]Continue Reading ...
Credit: CC0 Public Domain For a million American adults, living with type 1 diabetes means a constant need for insulin medication, blood sugar testing supplies and specialized care, to keep them healthy and prevent a crisis that could end up in an emergency room, a hospital bed or death. But a new study finds that […]Continue Reading ...
Home › News › FDA Alerts › SGLT2(sodium-glucose cotransporter-2) Inhibitors for Diabetes: Drug Safety Communication – Regarding Rare Occurrences of a Serious Infection of the Genital Area August 29, 2018 [Posted 08/29/2018] AUDIENCE: Patient, Endocrinology, Health Professional, Pharmacy ISSUE: FDA is warning that cases of a rare but serious infection of the genitals and area […]Continue Reading ...
Dr. Masuko Ushio-Fukai. Credit: Phil Jones, Senior Photographer, Augusta University In diabetes, both the tightly woven endothelial cells that line our blood vessels and the powerhouses that drive those cells start to come apart as early steps in the destruction of our vasculature. Now scientists have evidence that these breakups occur as another relationship falls […]Continue Reading ...
Credit: University of Gothenburg Properly composed treatment and refraining from cigarette consumption can significantly reduce the risk of cardiovascular disease resulting from type 2 diabetes, according to a study published in the New England Journal of Medicine. In some cases, the increased risks could theoretically be eliminated. “This is definitely good news. The study shows […]Continue Reading ...
Credit: CC0 Public Domain Polyneuropathy is one of the most common complications in people with diabetes. However, it can also occur with certain risk factors or diseases before the onset of diabetes. First symptoms are often pins-and-needles sensations in the feet. Although polyneuropathy is present in about 30 percent of people with diabetes, it often […]Continue Reading ...
A National Institutes of Health grant will help LSU Pennington Biomedical Research Center take the next step to better understanding how to prevent the kidney damage and failure caused by type 2 diabetes. Krisztian Stadler, PhD, director of the center’s Oxidative Stress and Disease Laboratory, won the NIH R01 grant valued at $1.75 million over […]Continue Reading ...
Physician researchers with The Ohio State University College of Medicine at the Wexner Medical Center say increased levels of the hormone aldosterone, already associated with hypertension, can play a significant role in the development of diabetes, particularly among certain racial groups. “This research is an important step toward finding new ways to prevent a major […]Continue Reading ...
Home › News › FDA Alerts › SGLT2 (sodium-glucose cotransporter-2) Inhibitors for Diabetes: Drug Safety Communication – Regarding Rare Occurrences of a Serious Infection of the Genital Area August 29, 2018 Audience: Patient, Endocrinology, Health Professional, Pharmacy ISSUE: FDA is warning that cases of a rare but serious infection of the genitals and area around […]Continue Reading ...
Immune reactions are usually a good thing-;the body’s way of eliminating harmful bacteria and other pathogens. But people also rely on molecular “brakes,” or checkpoints, to keep immune systems from attacking their own cells and organs and causing so-called autoimmune disease. Now, working with mice, Johns Hopkins researchers have discovered that in the rodent form […]Continue Reading ...
Credit: CC0 Public Domain Harmful effects of substances secreted from red blood cells could explain the increased risk of cardiovascular diseases in patients with type 2 diabetes, the results of two new studies conducted at Karolinska Institutet in Sweden indicate. The studies are published in the Journal of the American College of Cardiology and JACC: […]Continue Reading ...
A drug used to manage diabetes may reduce heart disease and death in people with diabetes regardless of their cholesterol levels and whether they are on a statin therapy, suggests a new analysis of the LEADER trial. The analysis suggests people with Type 2 diabetes and high cardiovascular risk have a lowered risk of death […]Continue Reading ...
- FDA takes new steps to address opioid crisis by approving Opioid Analgesic Risk Evaluation and Mitigation Strategy
- Positive Barhemsys Phase 3 Treatment Data Published in Anesthesia & Analgesia
- Celiac Disease Screening: MedlinePlus Lab Test Information
- Autism linked to egg cells’ difficulty creating large proteins
- Tweaking nuclear pores could provide new avenue to battle against cancer
- Experts warn health care providers to slow down in allowing smart pill in patient care settings
- MoreGrasp reports breakthrough development of grasp neuroprosthetics activated by thought control
- Study reveals new way to target HER2-negative metastatic breast cancer
- CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL
- Study offers solid link between visceral organs and brain’s reward, motivation system
- First U.S. patient treated with innovative gene therapy at Bascom Palmer Eye Institute
- Choroidal Detachment – The American Society of Retina Specialists
- Discovery of a key protein involved in the development of autism
- Henry Ford Health System receives $600k grant to study genetic makeup of gliomas
- Arthritis common in individuals with varying degrees of depression, finds study
- Scientist intends to fight pathogenic bacteria with viruses
- New research suggests link between PFAS chemicals and hyperthyroidism in pet cats
- Multi-year study data shows impact of new soft contact lens to slow myopia progression in children
- Neuroscientists identify circuit for brain’s statistical inference about motion
- MILabs’ VECTor6 system wins Commercial Innovation Award at WMIC 2018